Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With the Ancestral Strain and Omicron BA.2 Variant in Hong Kong

被引:15
|
作者
Wong, Jessica Y. [1 ]
Cheung, Justin K. [1 ]
Lin, Yun [1 ]
Bond, Helen S. [1 ]
Lau, Eric H. Y. [1 ,2 ]
Ip, Dennis K. M. [1 ]
Cowling, Benjamin J. [1 ,2 ,3 ]
Wu, Peng [1 ,2 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Contr, Sch Publ Hlth, Hong Kong, Peoples R China
[2] Lab Data Discovery Hlth Ltd, Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, 7 Sassoon Rd, Hong Kong, Peoples R China
来源
JOURNAL OF INFECTIOUS DISEASES | 2023年 / 228卷 / 09期
关键词
COVID-19; SARS-CoV-2; intrinsic; Omicron; severity; HOSPITALIZATION FATALITY RISK; INFLUENZA A(H1N1)PDM09; SARS-COV-2; COVID-19; CHINA;
D O I
10.1093/infdis/jiad236
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evaluating changes in COVID-19 severity over time is crucial when novel variants emerge. Intrinsic fatality risk was similar between Omicron and ancestral strains. Risk was inversely proportional to number of doses received, and higher risk was observed in older ages. Background Understanding severity of infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants is crucial to inform public health measures. Here we used coronavirus disease 2019 (COVID-19) patient data from Hong Kong to characterize the severity profile of COVID-19. Methods Time-varying and age-specific effective severity measured by case hospitalization risk and hospitalization fatality risk was estimated with all individual COVID-19 case data collected in Hong Kong from 23 January 2020 through 26 October 2022 over 6 epidemic waves. The intrinsic severity of Omicron BA.2 was compared with the estimate for the ancestral strain with the data from unvaccinated patients without previous infections. Results With 32 222 COVID-19 hospitalizations and 9669 deaths confirmed over 6 epidemic waves, the time-varying hospitalization fatality risk dramatically increased from <10% before the largest fifth wave of Omicron BA.2 to 41% during the peak of the fifth wave when hospital resources were severely constrained. The age-specific fatality risk in unvaccinated hospitalized Omicron cases was comparable to the estimates for unvaccinated cases with the ancestral strain. During epidemics predominated by Omicron BA.2, fatality risk was highest among older unvaccinated patients. Conclusions Omicron has comparable intrinsic severity to the ancestral Wuhan strain, although the effective severity is substantially lower in Omicron cases due to vaccination.
引用
收藏
页码:1231 / 1239
页数:9
相关论文
共 50 条
  • [31] Decreased Risk of Coronavirus Disease 2019-Related Hospitalization Associated With the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2
    Ridgway, Jessica P.
    Tideman, Samuel
    Wright, Bill
    Robicsek, Ari
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (07):
  • [32] Primary Series and Booster Coronavirus Disease 2019 Vaccine Effectiveness in a Cohort of Healthcare Workers in Albania During a BA.1 and BA.2 Variant Period, January-May 2022
    Finci, Iris
    Castro, Madelyn Yiseth Rojas
    Hasibra, Iris
    Sulo, Jonilda
    Fico, Albana
    Daja, Rovena
    Vasili, Adela
    Kota, Majlinda
    Preza, Iria
    Muhlemann, Barbara
    Drosten, Christian
    Pebody, Richard
    Lafond, Kathryn E.
    Kissling, Esther
    Katz, Mark A.
    Bino, Silvia
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (10):
  • [33] Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022
    Chen, Xinhua
    Yan, Xuemei
    Sun, Kaiyuan
    Zheng, Nan
    Sun, Ruijia
    Zhou, Jiaxin
    Deng, Xiaowei
    Zhuang, Tingyu
    Cai, Jun
    Zhang, Juanjuan
    Ajelli, Marco
    Yu, Hongjie
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 2800 - 2807
  • [34] Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA.4/5, and XBB dominance in Hong Kong: a prospective cohort study
    Wang, Yawei
    So, Hau Chi
    Tsang, Nicole Ngai Yung
    Kwok, Siu Kan
    Cowling, Benjamin J.
    Leung, Gabriel M.
    Ip, Dennis Kai Ming
    LANCET INFECTIOUS DISEASES, 2025, 25 (03): : 276 - 289
  • [35] Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study
    Fong, Carol Ho-Yan
    Zhang, Xiaojuan
    Chen, Lin-Lei
    Poon, Rosana Wing-Shan
    Chan, Brian Pui-Chun
    Zhao, Yan
    Wong, Carlos King-Ho
    Chan, Kwok-Hung
    Yuen, Kwok-Yung
    Hung, Ivan Fan-Ngai
    Yuen, Jacqueline Kwan Yuk
    To, Kelvin Kai-Wang
    EBIOMEDICINE, 2023, 88
  • [36] Air dispersal of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Implications for hospital infection control during the fifth wave of coronavirus disease 2019 (COVID-19) due to the SARS-CoV-2 omicron variant in Hong Kong
    Wong, Shuk-Ching
    Chan, Veronica Wing-Man
    Yuen, Lithia Lai-Ha
    Auyeung, Christine Ho-Yan
    Leung, Jessica Oi-Yan
    Li, Chi-Kuen
    Kwok, Monica Oi-Tung
    So, Simon Yung-Chun
    Chen, Jonathan Hon-Kwan
    Tam, Anthony Raymond
    Hung, Ivan Fan-Ngai
    To, Kelvin Kai-Wang
    Lo, Janice Yee-Chi
    Yuen, Kwok-Yung
    Cheng, Vincent Chi-Chung
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2023, 44 (08): : 1321 - 1324
  • [37] Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong
    Zhou, Runhong
    Liu, Na
    Li, Xin
    Peng, Qiaoli
    Yiu, Cheuk-Kwan
    Huang, Haode
    Yang, Dawei
    Du, Zhenglong
    Kwok, Hau-Yee
    Au, Ka-Kit
    Cai, Jian-Piao
    Hung, Ivan Fan-Ngai
    To, Kelvin Kai -Wang
    Xu, Xiaoning
    Yuen, Kwok-Yung
    Chen, Zhiwei
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 32
  • [38] Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters
    Su, Wen
    Choy, Ka Tim
    Gu, Haogao
    Sia, Sin Fun
    Cheng, Ka Man
    Nizami, Sarea Islam Nuha
    Krishnan, Pavithra
    Ng, Yuet Mai
    Chang, Lydia Dai Jia
    Liu, Yingzhi
    Cheng, Samuel M. S.
    Peiris, Malik
    Poon, Leo L. M.
    Nicholls, John M.
    Yen, Hui Ling
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (10): : 1143 - 1152
  • [39] Association of COVID-19 with acute and post-acute risk of multiple different complications and mortality in patients infected with omicron variant stratified by initial disease severity: a cohort study in Hong Kong
    Wan, Eric Yuk Fai
    Zhang, Ran
    Mathur, Sukriti
    Yan, Vincent Ka Chun
    Lai, Francisco Tsz Tsun
    Chui, Celine Sze Ling
    Li, Xue
    Wong, Carlos King Ho
    Chan, Esther Wai Yin
    Lau, Chak Sing
    Wong, Ian Chi Kei
    BMC MEDICINE, 2024, 22 (01):
  • [40] Asthma control after recovery from mild to moderate COVID-19: from Omicron BA.2 to XBB- from a cohort in a university hospital in Hong Kong
    Kwok, Wang Chun
    Tsui, Chung Ki
    Tam, Terence Chi Chun
    Lam, David Chi Leung
    Ip, Mary Sau Man
    Ho, James Chung Man
    BMC PULMONARY MEDICINE, 2025, 25 (01):